Characterisation of a novel group B oncolytic adenovirus, ColoAd1

<p>Developing high potent oncolytic virus with multimodal antitumour capabilities is crucial for realizing the full potential of oncolytic virotherapy in cancer treatment. ColoAd1 is a novel replicating chimeric group B adenovirus recently bioselected from a large library of recombinant virus...

Full description

Bibliographic Details
Main Author: Di, Y
Other Authors: Seymour, L
Format: Thesis
Language:English
Published: 2011
Subjects: